J.K.E. Veraart

Faculty of Medical Sciences

Telephone:

+31 50 361 2065

E-mail:

j.k.e.veraart umcg.nl

Research Portal

Publications

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension

Smith-Apeldoorn, S. Y., Veraart, J. K. E., Kamphuis, J., Spijker, J., van der Meij, A., van Asselt, A. D. I., aan het Rot, M. & Schoevers, R. A., Sept-2024, In: Molecular Psychiatry. 29, p. 2657–2665 9 p.

Research output: Contribution to journal › Article › Academic › peer-review

Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Schimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W. & Schoevers, R. A., Aug-2023, In: Psychopharmacology. 240, 1 p., 1823.

Research output: Contribution to journal › Erratum

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study

Breeksema, J. J., Niemeijer, A., Kuin, B., Veraart, J., Vermetten, E., Kamphuis, J., van den Brink, W. & Schoevers, R., Jul-2023, In: Psychopharmacology. 240, 7, p. 1547-1560 14 p.

Research output: Contribution to journal › Article › Academic › peer-review

Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder

Veraart, J. K. E., van Westenbrugge, M., van Wulfften Palthe, J. E., van der Meij, A., Schoevers, R. A. & de Jong, J., May-2023, In: Heliyon. 9, 5, 6 p., e15883.

Research output: Contribution to journal › Article › Academic › peer-review

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study

Breeksema, J. J., Niemeijer, A., Kuin, B., Veraart, J., Kamphuis, J., Schimmel, N., van den Brink, W., Vermetten, E. & Schoevers, R., 25-Nov-2022, In: Frontiers in Psychiatry. 13, 16 p., 948115.

Research output: Contribution to journal › Article › Academic › peer-review

Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability

Smith-Apeldoorn, S. Y., Veraart, J. K., Spijker, J., Kamphuis, J. & Schoevers, R. A., Nov-2022, In: The Lancet Psychiatry. 9, 11, p. 907-921 15 p.

Research output: Contribution to journal › Review article › peer-review

Psilocybine versus escitalopram bij depressieve stoornis

Van Westenbrugge, M. & Veraart, J., Feb-2022, In: Tijdschrift voor Psychiatrie. 64, p. 117 1 p.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Schimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W. & Schoevers, R. A., Jan-2022, In: Psychopharmacology. 239, p. 15–33 19 p.

Research output: Contribution to journal › Review article › peer-review

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study

Smith-Apeldoorn, S. Y., Veraart, J. K. E., Ruhé, H. G., Aan Het Rot, M., Kamphuis, J., de Boer, M. K. & Schoevers, R. A., Jan-2022, In: BJPsych Open. 8, 1, 6 p., 4.

Research output: Contribution to journal › Article › Academic › peer-review

Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression: A Systematic Literature Review and Case Series

Veraart, J. K. E., Smith-Apeldoorn, S. Y., Kutscher, M., Vischjager, M., van der Meij, A., Kamphuis, J. & Schoevers, R. A., 24-Oct-2022, In: The Journal of clinical psychiatry. 83, 6, 10 p., 21m14267.

Research output: Contribution to journal › Review article › peer-review